Blue Trust’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$71.4K Buy
4,031
+5
+0.1% +$84 ﹤0.01% 1107
2026
Q2
$63.9K Sell
4,026
-301
-7% -$4.66K ﹤0.01% 1249
2026
Q1
$58.5K Sell
4,327
-34
-0.8% -$476 ﹤0.01% 1256
2025
Q4
$54.3K Sell
4,361
-53
-1% -$572 ﹤0.01% 1332
2025
Q3
$43.7K Buy
4,414
+1,420
+47% +$13.8K ﹤0.01% 1456
2025
Q2
$26.7K Sell
2,994
-795
-21% -$6.72K ﹤0.01% 1603
2025
Q1
$33K Sell
3,789
-558
-13% -$5.86K ﹤0.01% 1530
2024
Q4
$54.1K Sell
4,347
-3,513
-45% -$43.2K ﹤0.01% 1272
2024
Q3
$83.6K Buy
7,860
+1,984
+34% +$22.9K ﹤0.01% 1315
2024
Q2
$70.2K Buy
5,876
+949
+19% +$10.5K ﹤0.01% 1119
2024
Q1
$58.8K Sell
4,927
-4,247
-46% -$51.2K ﹤0.01% 861
2023
Q4
$90K Buy
9,174
+717
+8% +$6.87K ﹤0.01% 725
2023
Q3
$84K Buy
8,457
+4,731
+127% +$49.3K ﹤0.01% 675
2023
Q2
$35K Sell
3,726
-3,740
-50% -$35.7K ﹤0.01% 836
2023
Q1
$83K Sell
7,466
-502
-6% -$5.57K ﹤0.01% 837
2022
Q4
$68K Buy
7,968
+3,705
+87% +$38.7K ﹤0.01% 799
2022
Q3
$44K Buy
4,263
+47
+1% +$463 ﹤0.01% 796
2022
Q2
$46K Buy
+4,216
New +$46.2K ﹤0.01% 712

Other funds holding VTRS

Blue Trust's VTRS Position: Q3 2026 in Review

Blue Trust increased its Viatris (VTRS) stake by 0.12% in Q3 2026, buying an estimated $84 and bringing the position to 4,031 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

Blue Trust first reported a position in VTRS in Q2 2022 and has held it in 18 quarters since. The position peaked at $90K in Q4 2023. 886 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • Blue Trust held 4,031 shares of Viatris worth $71.4K as of Q3 2026.
  • Blue Trust bought 5 Viatris shares in Q3 2026, an estimated $84.
  • Viatris made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1107 holding.
  • Blue Trust first reported a position in Viatris in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Viatris position peaked at $90K in Q4 2023.
  • 886 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.